Key To Drug Marketing: Evolve, Evolve, Evolve
This article was originally published in The Pink Sheet Daily
Drug companies looking to maintain successful marketing platforms in the social media age must change messages with the technology.
You may also be interested in...
Drugmakers must start monitoring adverse event data and product discussions on the Internet or run the risk of facing legal scrutiny, marketing specialists said at a Feb. 25 Drug Information Association conference in New York City
FDA's spate of five promotional citations to manufacturers of attention deficit/hyperactivity disorder drugs signals that the agency intends to remain vigilant in oversight of new media
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.